Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 1988 2019

Filtrer
Letter
2019

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study

Plesner, T., Arkenau, H. T., Gay, F., Minnema, M. C., Boccadoro, M., Moreau, P., Cavenagh, J., Perrot, A., Laubach, J. P., Krejcik, J., Ahmadi, T., de Boer, C., Chen, D., Chiu, C., Schecter, J. M. & Richardson, P. G., aug. 2019, I : British Journal of Haematology. 186, 3, s. e35-e39

Publikation: Bidrag til tidsskriftLetterForskningpeer review